, , , , ,

Genetically-modified, redirected T cells target hepati-tis B surface antigen-positive hepatocytes and hepato-cellular carcinoma lesions in a clinical setting

|

免责声明:本网站目的在于科普相关知识传播,非盈利性质,全部资料均来源于网络,如有侵权请联系删除